Product Information
FEBUXOSTAT 40 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.2128 per EA under NDC 62332019030. Its NADAC has been published 354 times since Sep 18, 2019.
Strength
40 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332019030
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FEBUXOSTATApproval Type
Generic (ANDA)
FDA Application
ANDA205421On Market Since
7/1/2019
Pharmacological Classes
Price Statistics
The NADAC for FEBUXOSTAT 40 MG TABLET has been published 354 times since Sep 18, 2019, and over the history we have for it it has declined 96.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2128 per EA |
|---|---|
| All-time high | $6.9447 (Oct 16, 2019) |
| All-time low | $0.2016 (Jan 21, 2026) |
| 52-week high | $0.3713 |
| 52-week low | $0.2016 |
| Median price | $0.6504 |
| Average price | $1.1765 |
| Largest weekly change | -33.0% (Apr 22, 2020) |
| Weeks tracked | 354 |
| Tracking since | Sep 18, 2019 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FEBUXOSTAT 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 40 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.2128 per EA (NDC 62332019030), effective Jun 24, 2026.
How has the price of FEBUXOSTAT 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEBUXOSTAT 40 MG TABLET has declined 96.9%. It has been tracked across 354 weekly CMS publications since Sep 18, 2019.
What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 40 MG TABLET?
Since Sep 18, 2019, the NADAC for FEBUXOSTAT 40 MG TABLET has ranged from a low of $0.2016 (Jan 21, 2026) to a high of $6.9447 (Oct 16, 2019), with a median of $0.6504 per EA.
Are there cheaper alternatives to FEBUXOSTAT 40 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as FEBUXOSTAT 40 MG TABLET, but none are currently priced below it.
Who manufactures FEBUXOSTAT 40 MG TABLET?
FEBUXOSTAT 40 MG TABLET (NDC 62332019030) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification